Choroidal Melanoma clinical trials

Explore recruiting choroidal melanoma clinical trials.

Recruiting choroidal melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Choroidal Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma

Czechia, Spain, Belgium, Italy, Austria, Germany +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Choroidal Melanoma trials by city

Choroidal Melanoma in Toronto Choroidal Melanoma in Vancouver Choroidal Melanoma in Montreal Choroidal Melanoma in Calgary Choroidal Melanoma in Edmonton Choroidal Melanoma in Ottawa Choroidal Melanoma in Winnipeg Choroidal Melanoma in Quebec City Choroidal Melanoma in Hamilton Choroidal Melanoma in Kitchener Choroidal Melanoma in London Choroidal Melanoma in Halifax Choroidal Melanoma in New York Choroidal Melanoma in Los Angeles Choroidal Melanoma in Chicago Choroidal Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease